Nemoto M, Nishimura R, Sasaki T, Hiki Y, Miyashita Y, Nishioka M, Fujimoto K, Sakuma T, Ohashi T, Fukuda K, Eto Y, Tajima N
Other optional add-ins may include carbohydrates, fats, fiber, sweeteners, and stabilizers, so nutrition profiles can vary significantly across brands
Science 359, 11511156
Side Effects by System Detailed Management Gastrointestinal (Most Common) Affects 1544% of patients depending on dose and indication
A: While there have been initial concerns, large randomized trials have not proven a causal link between GLP-1 agonists and conditions like pancreatitis or pancreatic cancer